Current Opinion in Nephrology and Hypertension was launched in 1992. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of nephrology and hypertension is divided into 12 sections that are each reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Maarten Taal graduated from the University of Cape Town Medical School, South Africa, in 1987. After completing his post-graduate training in internal medicine and nephrology at Groote Schuur Hospital, Cape Town, he joined the Laboratory of Kidney and Electrolyte Physiology at Brigham and Women's Hospital, Boston, USA under the directorship of Barry M. Brenner. His research focused on mechanisms underlying the progression of chronic kidney disease and earned him a Doctor of Medicine degree. He subsequently moved to the United Kingdom where he was appointed a Consultant Renal Physician at Derby City General Hospital in 2002 and Special Lecturer at the University of Nottingham Medical School in 2006. His current research interests include Chronic Kidney Disease Progression, Diabetic Nephropathy, Renal Osteodystrophy and Cardiovascular Disease in Chronic Kidney Disease (CKD) patients. He is a member of the Centre for Integrated Systems in Medicine and Biology at the University of Nottingham. He has written chapters on CKD and the management of CKD Progression in several major nephrology text books. He has published original research as well as review articles in most major nephrology journals.
Jonathan Himmelfarb graduated from George Washington University School of Medicine and completed the medical residency program at the Maine Medical Center. After finishing his nephrology fellowship at Brigham and Women's Hospital in Boston in 1998 he continued his career as a member of Maine Medical Center Division of Nephrology and Transplantation. In 1997 Dr Himmelfarb was appointed the Director of the Division of Nephrology and Transplantation at the Maine Medical Center, where he also became the Associate Chair for Research in the Department of Medicine, and served as Director of Clinical and Translational Research at the Maine Medical Center Research Institute. Since June 2008, Dr Himmelfarb is Director of the Kidney Research Institute, Professor of Medicine, and holds the Joseph W. Eschbach M.D. Endowed Chair in Kidney Research the University of Washington.
Dr Himmelfarb has served on numerous study sections and grant review committees. He has been Chairman for the American Society of Nephrology Dialysis Advisory Group and is currently Chairman of the American Society of Nephrology's Public Policy Board. He has served on the Scientific Advisory Boards of the United Network for Organ Sharing, the National Kidney Foundation, and the Satellite Healthcare Research Foundation. Since 2002, he has been a member of the American Board of Internal Medicine Subspecialty Board on Nephrology. Dr Himmelfarb served as on the Editorial Boards of the Journal of the American Society of Nephrology and Kidney International, and is currently North American editor for Dialysis and Renal Transplantation for the Faculty of 1000 in Medicine. He has served on program committees for the World Congress of Nephrology, American Society of Nephrology, and the Renal Research Institute. He is the author of more than 140 peer-reviewed publications, including original research, reviews, and editorials. His current research includes biomarkers of cardiovascular risk in chronic kidney disease, studies of oxidative stress in chronic kidney disease, performance of randomized clinical trials as part of the NIDDK Dialysis Access Consortium, and studies of metabolic alterations in acute kidney injury.
Steven Sacks is Professor of Nephrology and Head of the Department of Nephrology and Transplantation at King's College London School of Medicine. After gaining a PhD at the Laboratory of Molecular Biology in Cambridge, he completed his nephrology training in Oxford and Cambridge, and has since been based at Guy's Hospital in London. His main research interest is in complement and renal disease, in particular the regulation of local synthesis of compliment and its effect on alloimmunity and antimicrobial defence. Professor Sacks also has an interest in Medical Ethics and serves on the Medical Research Council and Wellcome Trust grants award panels.